Dispersome is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Beta-lactoglobulin as pharmaceutical excipient
Proteins comprise a new group of excipients for preparing amorphous solid dispersions. Beta-lactoglobulin (BLG), the main component in Dispersomes, results in superior drug solubility compared to other proteins. Zerion Pharma has a strong IP portfolio covering protein-based excipients for solid dispersions with patent life beyond 2040.
Stable formulations with high drug loading
The use of Dispersome technology enables drug loadings above 50% w/w while maintaining stability and improving API solubility. At a drug loading of 50%, stable amorphous formulations are obtained for more than 80% of all drugs tested.
A safe and manufacturable excipient
We work with world leading suppliers to source and qualify our BLG material, ensuring high quality and large scale. BLG is a natural ingredient used in food and nutrition products and is easy to integrate in your existing processes.
Superior outcomes, compatible technology
By increasing drug solubility, the Dispersome platform aims at improving oral bioavailability and therapeutic outcomes for patients. Dispersome formulations are compatible with standard pharmaceutical processes and Spray Drying provides a scalable manufacturing solution for Dispersomes.
Your preferred solubility partner
We invite you to test the performance of our Dispersome technology in a fast and informative feasibility study. We have successfully used this technology on multiple drug molecules from pharma companies.
See the full technical brochure on Dispersome Make your drugs soluble here
(click the picture to download the brochure)
Source: Zerion, technical brochure Dispersome Make your drugs soluble









































All4Nutra











